Genomic medicine offers hope for improved diagnostic methods and for more effective, patient-specific therapies. Genome-wide associated studies (GWAS) elucidate genetic markers that improve understanding of risks and causes for many diseases, and may guide diagnosis and therapy on a patient-specific basis. This project will take another approach to identify gene-disease associations: perform """"""""reverse GWAS,"""""""" or phenome- wide association study (PheWAS), to determine which phenotypes are associated with a given genotype. The project is enabled by a large DNA biobank coupled to a de- identified copy of the electronic medical record. This project has four specific aims. First, the project will develop and validate a standardized approach to extract disease phenotypes from EMR records, integrating national standard terminologies of clinical disorders and descriptors relating to treatment and diagnosis of each disease to create a sharable knowledge base. The project will use natural language processing, structured data queries, and heuristic and machine learning methods to accurately identify patients with each disease and corresponding controls.
The second aim i s to perform PheWAS analyses using existing genotype data. To validate the method, the project will use PheWAS to """"""""rediscover"""""""" SNPs with known disease associations. The project will also investigate statistical methods for large-scale multiple hypothesis testing to discover novel phenotype associations.
The third aim i s to apply the PheWAS algorithms in four other sites with EMR-linked DNA biobanks and compare results. In the fourth aim, the project will validate novel phenotype-genotype associations discovered through PheWAS with new genotyping in a previously untested population. The tools generated from this project will not only make PheWAS possible, but will also broadly enable clinical research and subsequent genetic studies.
The promise of genomic medicine is to predict individuals'disease risk and treatment given their genetic information. This project will develop methods to identify diseases from electronic medical records and then find novel genetic associations from existing genomic data.
|Mosley, Jonathan D; Shoemaker, M Benjamin; Wells, Quinn S et al. (2017) Investigating the Genetic Architecture of the PR Interval Using Clinical Phenotypes. Circ Cardiovasc Genet 10:|
|Doss, Jayanth; Mo, Huan; Carroll, Robert J et al. (2017) Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia. Arthritis Rheumatol 69:291-300|
|Doss, Jayanth; Mo, Huan; Carroll, Robert J et al. (2017) Reply. Arthritis Rheumatol 69:680-681|
|Karnes, Jason H; Shaffer, Christian M; Bastarache, Lisa et al. (2017) Comparison of HLA allelic imputation programs. PLoS One 12:e0172444|
|Boortz, Kayla A; Syring, Kristen E; Pound, Lynley D et al. (2017) Effects of G6pc2 deletion on body weight and cholesterol in mice. J Mol Endocrinol 58:127-139|
|Teixeira, Pedro L; Wei, Wei-Qi; Cronin, Robert M et al. (2017) Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individuals. J Am Med Inform Assoc 24:162-171|
|Dohn, Michael R; Kooker, Christopher G; Bastarache, Lisa et al. (2017) The Gain-of-Function Integrin ?3 Pro33 Variant Alters the Serotonin System in the Mouse Brain. J Neurosci 37:11271-11284|
|Karol, S E; Larsen, E; Cheng, C et al. (2017) Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia. Leukemia 31:1325-1332|
|Robinson, Jamie R; Denny, Joshua C; Roden, Dan M et al. (2017) Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records. Clin Transl Sci :|
|Denny, Joshua C; Van Driest, Sara L; Wei, Wei-Qi et al. (2017) The influence of big (clinical) data and genomics on precision medicine and drug development. Clin Pharmacol Ther :|
Showing the most recent 10 out of 63 publications